|
Home > Articles
Post-treatment imaging of liver tumours
Abstract
In the past few years, great improvements have been made to achieve local tumour control of primary liver malignancies and liver metastases. For hepatocellular carcinoma (HCC), transarterial chemoembolisation (TACE) and
tumour ablation techniques, including percutaneous ethanol injection (PEI), radiofrequency ablation (RF), and laserinduced interstitial thermotherapy (LITT) have been developed. For colorectal liver metastases, surgery is still the standard technique in localised disease, although percutaneous RF ablation has gained considerable acceptance. In patients with widespread disease, chemotherapy with new drugs offers improved survival. Contrast-enhanced
computed tomography (CT) and magnetic resonance imaging (MRI) are the modalities of choice to evaluate treatment response. The present review demonstrates imaging findings of complete and incomplete tumour control
after intervention as well as the imaging spectrum of complications. Imaging guidelines according to the World Health Organization and Response Evaluation Criteria In Solid Tumors (RECIST) for assessment of chemotherapy
response are presented.
Author
Wolfgang Schima, Ahmed Ba-Ssalamah, Amir Kurtaran, Martin Schindl and Thomas Gruenberger
Contact Details
Corresponding address:
Prof. Dr Wolfgang Schima; MSc, Department of Radiology, Medical University of Vienna,
Waehringer Guertel 1820, A-1090 Vienna, Austria
Reference
ICIS Cancer Imaging Volume 7 Special Issue A
DOI: 10.1102/1470-7330.2007.9047
Date Posted
1 October 2007
Open Access is provided for this article.
Print PDF
Size
1.10 MB
Minimum Estimated Download Times
ADSL 2Mb/s (Broadband): |
4 seconds |
ADSL 512Kb/s (Broadband): |
17 seconds |
64 Kb/s (ISDN): |
2 minutes 20 seconds |
33.3 Kb/s (Typical Modem): |
4 minutes 29 seconds |
|
